Clinical Study Site

Cleveland, Ohio 44195

2 studies enrolling now · 4 studies all time

What they study most

Bleeding, Metastatic Colorectal Cancer (CRC), Non-Small Cell Lung Cancer, Paroxysmal Nocturnal Hemoglobinuria (PNH)

Studies at this site

• Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer — Recruiting now
• Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1 — Recruiting now
• Study of Danicopan in Participants With Paroxysmal Nocturnal Hemoglobinuria With Inadequate Response to Eculizumab — Completed
• A Study in Participants With Acute Major Bleeding to Evaluate the Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Direct and Indirect Oral Anticoagulants (Extension Study) — Completed